Adaptive Dose-Ranging Designs in Clinical Trials


WEBINAR | Recorded November 20, 2008


Take part in the second in our series of online discussions hosted by thought leaders in adaptive design.

Insufficient exploration of a dose-response relationship often leads to the use of a poorly chosen optimal dose in a confirmatory trial that can result in trial failure or the collapse of the clinical program. While regulatory agencies prefer to limit the use of adaptive designs in confirmatory trials, they support the deployment of appropriately planned adaptive designs in dose-ranging studies.

Register today for this informative webinar led by members of i3 Statprobe’s Adaptive Design Consulting Group. Join us online as we:

  • Review the most common adaptive methods used in dose-ranging studies
  • Demonstrate two adaptive dose-response methods based on both efficacy and safety as case studies
  • Respond to your queries in real time
We hope you’ll be able to join us for this complimentary interactive one-hour discussion where you’ll have the opportunity to send us your questions and comments during the webinar.

www.i3statprobe.com

 




 
This message was sent by i3 Statprobe | 300 West Morgan | Ann Arbor, MI 48108 USA
(866) 658-4644 |
info@i3statprobe.com | www.i3Statprobe.com
© 2008 Ingenix, Inc. | 100-0948

 
Register Now!